Bluejay Diagnostics (BJDX) Total Non-Current Liabilities (2020 - 2026)

Bluejay Diagnostics has reported Total Non-Current Liabilities for 6 years, with the latest figure at $1.4 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 0.7% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 0.7% YoY) and the FY2025 annual result came in at $1.1 million, up 23.94% from the prior year.
• Total Non-Current Liabilities rose to $1.4 million in Q1 2026 per BJDX's latest filing, from $1.1 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $3.0 million in Q3 2023 and troughed at $919357.0 in Q4 2024.
• A 5-year average of $1.7 million and a median of $1.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities jumped 60.72% in 2023, then tumbled 60.95% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $2.0 million in 2022, then slipped by 0.14% to $2.0 million in 2023, then tumbled by 53.13% to $919357.0 in 2024, then advanced by 23.94% to $1.1 million in 2025, then increased by 24.09% to $1.4 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.4 million, $1.1 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.